drugset / Trial / NCT01103414
Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of three dose levels of Mitoglitazone™ (MSDC-0160) in patients with type 2 diabetes.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-11
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitoglitazone | Small molecule | 50 mg | — |
| Subject | Mitoglitazone | Small molecule | 100 mg | — |
| Subject | Mitoglitazone | Small molecule | 150 mg | — |
| Comparator | Pioglitazone | Small molecule | 45 mg | — |